Evelo Biosciences (EVLO) Competitors $0.0005 0.00 (0.00%) As of 04/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock EVLO vs. SMFL, VAXX, SCPS, CMRA, GNCAQ, GNCA, ARDS, CALA, STAB, and PXMDShould you be buying Evelo Biosciences stock or one of its competitors? The main competitors of Evelo Biosciences include Smart for Life (SMFL), Vaxxinity (VAXX), Scopus BioPharma (SCPS), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Calithera Biosciences (CALA), Statera Biopharma (STAB), and PaxMedica (PXMD). These companies are all part of the "pharmaceutical products" industry. Evelo Biosciences vs. Smart for Life Vaxxinity Scopus BioPharma Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Calithera Biosciences Statera Biopharma PaxMedica Smart for Life (NASDAQ:SMFL) and Evelo Biosciences (NASDAQ:EVLO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, community ranking, valuation and profitability. Does the MarketBeat Community prefer SMFL or EVLO? Evelo Biosciences received 169 more outperform votes than Smart for Life when rated by MarketBeat users. However, 100.00% of users gave Smart for Life an outperform vote while only 60.50% of users gave Evelo Biosciences an outperform vote. CompanyUnderperformOutperformSmart for LifeOutperform Votes1100.00% Underperform VotesNo VotesEvelo BiosciencesOutperform Votes17060.50% Underperform Votes11139.50% Is SMFL or EVLO more profitable? Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Evelo Biosciences N/A N/A N/A Do insiders & institutionals hold more shares of SMFL or EVLO? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 0.3% of Evelo Biosciences shares are held by institutional investors. 31.7% of Smart for Life shares are held by company insiders. Comparatively, 1.0% of Evelo Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has better earnings and valuation, SMFL or EVLO? Smart for Life has higher revenue and earnings than Evelo Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.00-$22.68MN/AN/AEvelo BiosciencesN/AN/A-$114.53MN/AN/A Which has more volatility and risk, SMFL or EVLO? Smart for Life has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Comparatively, Evelo Biosciences has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Does the media favor SMFL or EVLO? In the previous week, Evelo Biosciences had 2 more articles in the media than Smart for Life. MarketBeat recorded 2 mentions for Evelo Biosciences and 0 mentions for Smart for Life. Evelo Biosciences' average media sentiment score of 0.58 beat Smart for Life's score of 0.00 indicating that Evelo Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Smart for Life Neutral Evelo Biosciences Positive SummarySmart for Life beats Evelo Biosciences on 6 of the 9 factors compared between the two stocks. Get Evelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EVLO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVLO vs. The Competition Export to ExcelMetricEvelo BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$9,000.00$6.46B$5.31B$7.35BDividend YieldN/A3.20%5.45%4.29%P/E RatioN/A6.9521.9417.82Price / SalesN/A231.03380.9597.68Price / CashN/A65.6738.2634.64Price / BookN/A5.936.453.98Net Income-$114.53M$143.22M$3.22B$247.81M1 Month PerformanceN/A-13.56%-9.76%-7.91%1 Year PerformanceN/A-8.89%11.49%1.53% Evelo Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9,000.00N/A0.00120Upcoming EarningsOptions VolumeNews CoverageSMFLSmart for LifeN/A$0.00+38.5%N/A-100.0%$26,000.00$11.11M0.00110Gap DownVAXXVaxxinityN/A$0.00-99.5%N/A-97.8%$25,000.00N/A0.0090Gap DownSCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009CMRAComera Life SciencesN/A$0.00flatN/AN/A$6,000.00$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00N/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070Analyst ForecastNews CoverageARDSAridis PharmaceuticalsN/AN/AN/AN/A$5,000.00$3.09M0.0030CALACalithera BiosciencesN/A$0.00+66.7%N/A-80.0%$5,000.00N/A0.0060Analyst ForecastNews CoverageSTABStatera BiopharmaN/A$0.00flatN/A-83.3%$5,000.00N/A0.0020PXMDPaxMedicaN/A$0.00flatN/A-100.0%$2,000.00N/A0.002 Related Companies and Tools Related Companies SMFL Alternatives VAXX Alternatives SCPS Alternatives CMRA Alternatives GNCAQ Alternatives GNCA Alternatives ARDS Alternatives CALA Alternatives STAB Alternatives PXMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EVLO) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EVLO Stock Free EVLO Stock Alerts